Pancreatic Cancer Research

ResearcherUniversity of PaduaNo recent work listed

Stefania Moz

Matched on ORCID iD 0000-0002-7485-520X; OpenAlex author ID A5001320749. Sources: OpenAlex.

Their work

Papers
12
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 2 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: 2 papers · 2022: none · 2023: 2 papers

Papers 12

  1. The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer. Co-author DOI 10.1016/j.critrevonc.2023.104020↗
  2. Genetic and non-genetic risk factors for early-onset pancreatic cancer. Co-author DOI 10.1016/j.dld.2023.02.023↗
  3. Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility. Co-author DOI 10.1002/ijc.33475↗
  4. Identification of Recessively Inherited Genetic Variants Potentially Linked to Pancreatic Cancer Risk. Co-author DOI 10.3389/fonc.2021.771312↗
  5. Genome-wide association study identifies an early onset pancreatic cancer risk locus. Co-author DOI 10.1002/ijc.33004↗
  6. Vitamin D Prevents Pancreatic Cancer-Induced Apoptosis Signaling of Inflammatory Cells. Co-author DOI 10.3390/biom10071055↗
  7. PDAC-derived exosomes enrich the microenvironment in MDSCs in a SMAD4-dependent manner through a new calcium related axis. Co-author DOI 10.18632/oncotarget.20863↗
  8. Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mell… Co-author DOI 10.1016/j.cca.2016.02.018↗
  9. SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells. Co-author DOI 10.18632/oncotarget.12068↗
  10. Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1. Co-author DOI 10.1186/1478-811x-12-20↗
  11. Usefulness of MALDI-TOF/MS identification of low-MW fragments in sera for the differential diagnosis of pancreatic cancer. Co-author DOI 10.1097/mpa.0b013e318273096c↗
  12. Altered intracellular calcium fluxes in pancreatic cancer induced diabetes mellitus: Relevance of the S100A8 N-terminal peptide (NT-S100A8). Co-author DOI 10.1002/jcp.22355↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daniela Basso · 7 shared papers, 2011–2020 · strength 0.38
  2. Mario Plebani · 7 shared papers, 2011–2020 · strength 0.38
  3. Sergio Pedrazzoli · 6 shared papers, 2011–2017 · strength 0.24
  4. Andrea Padoan · 6 shared papers, 2011–2017 · strength 0.24
  5. Paola Fogar · 5 shared papers, 2011–2017 · strength 0.19
  6. Cosimo Sperti · 2 shared papers, 2013–2016 · strength 0.08
  7. Ada Aita · 1 shared paper, 2017 · strength 0.05
  8. Matteo Fassan · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.